pcasanueva, Author at SISAQOL

About pcasanueva

This author has not yet filled in any details.
So far pcasanueva has created 8 blog entries.

Third SISAQOL-IMI Consensus Meeting

pcasanueva2025-03-12T15:40:14+01:00

Third SISAQOL-IMI Consensus Meetingpcasanueva2025-03-12T15:40:14+01:00

Second SISAQOL-IMI Consensus Meeting

pcasanueva2025-03-12T15:40:56+01:00

Second SISAQOL-IMI Consensus Meetingpcasanueva2025-03-12T15:40:56+01:00

Standardizing the design, analysis, and interpretation of patient-reported outcomes in cancer clinical trials

pcasanueva2025-03-12T15:41:49+01:00

Standardizing the design, analysis, and interpretation of patient-reported outcomes in cancer clinical trialspcasanueva2025-03-12T15:41:49+01:00

PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI

pcasanueva2025-03-12T15:42:37+01:00

PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMIpcasanueva2025-03-12T15:42:37+01:00

Collaborating for consensus

pcasanueva2025-03-12T15:43:56+01:00

Collaborating for consensuspcasanueva2025-03-12T15:43:56+01:00

Kick off press release for SISAQOL-IMI

pcasanueva2025-03-12T15:44:33+01:00

Kick off press release for SISAQOL-IMIpcasanueva2025-03-12T15:44:33+01:00

Read our systematic review on patient-reported outcomes in metastatic breast cancer

pcasanueva2025-03-12T15:45:16+01:00

Read our systematic review on patient-reported outcomes in metastatic breast cancerpcasanueva2025-03-12T15:45:16+01:00

The SISAQOL initiative during the 5th EORTC Quality of Life Conference in Brussels

pcasanueva2025-03-12T15:45:46+01:00

The SISAQOL initiative during the 5th EORTC Quality of Life Conference in Brusselspcasanueva2025-03-12T15:45:46+01:00

The SISAQOL-IMI Project has received funding from the Innovative Health Initiative 2 joint undertaking under grant agreement No 945052. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.